BY JULIE SCHONNING

Epkinly, marketed in Europe as Tekinly, was just recently authorized as a therapy on the United States market.

Complying with stage II tests, the pharmaceutical business is enthusiastic that bexicaserin will certainly have the ability to assist people with extreme and unusual types of epile…